A metabolite-based resistance mechanism against malaria

Area of Science:

• Malaria pathogenesis
• Bilirubin metabolism
• Host-parasite interactions

Background:

• Jaundice is common in Plasmodium falciparum malaria due to bilirubin accumulation.
• The role of jaundice in malaria (adaptive vs. maladaptive) is unclear.
• Asymptomatic malaria shows higher unconjugated to conjugated bilirubin ratios and parasite burden.

Purpose of the Study:

• To investigate the role of bilirubin metabolism in Plasmodium falciparum malaria.
• To determine if jaundice is a protective or detrimental host response.
• To elucidate the mechanisms by which bilirubin affects parasite virulence.

Main Methods:

• Investigated human malaria cases for bilirubin profiles and parasite burden.
• Utilized mouse models with genetic alterations in bilirubin synthesis (biliverdin reductase A - BVRA) and conjugation (UDP glucuronosyltransferase family 1 member A1 - UGT1A1).
• Assessed parasite proliferation, virulence, and survival in response to varying bilirubin levels.

Main Results:

• Genetic suppression of bilirubin synthesis (BVRA) increased malaria mortality in mice.
• Increased unconjugated bilirubin (via UGT1A1 inhibition) protected mice against malaria.
• Unconjugated bilirubin inhibited P. falciparum proliferation by suppressing mitochondrial pyrimidine synthesis.
• Unconjugated bilirubin disrupted parasite hemozoin crystallization and food vacuole function.

Conclusions:

• Jaundice, characterized by elevated unconjugated bilirubin, is a protective metabolic response to Plasmodium spp. infection.
• This response limits malaria severity by directly inhibiting parasite growth and function.
• Understanding bilirubin's role offers potential therapeutic targets for malaria.